abstract |
Pharmaceutical compositions containing erythromycin, nor an ester thereof, and inosine, or an acidic derivative nthereof, in molar ratios varying from 5:1 to 1:5, particularly in nthe form of a salt of erythromycin dipropionate (or of erytnhromycin ethylsuccinate) with inosinic acid in the molar ratio n2:1, display antibiotic and immunostimulating properties, nwhich make them particularly useful from the therapeutic npoint of view. |